HCP Live May 31, 2024
Healthcare professionals who were aware of the safety and efficacy of biosimilars were more likely to prescribe or switch patients to a biosimilar.
A US-based online survey revealed varied attitudes among healthcare providers and pharmacists towards biosimilars, emphasizing the need for better organization in biosimilar guidelines, according to a study published in Innovations in Pharmacy.1
Particularly, results highlighted the ongoing need for education on biosimilar manufacturing pathways among pharmacists and providers, which helps standardize legislation and supports the continued use of biosimilars.
The introduction of interchangeable biosimilars created an opportunity to increase patient access while the cutting costs associated with biologics. Despite this, many clinicians have voiced their hesitancy on prescribing or switching their patients to biosimilars, citing concerns about...
Today's Sponsors
Today's Sponsor